Aurora Cannabis (ACB) Notes Payables (2018 - 2025)

Aurora Cannabis (ACB) has 8 years of Notes Payables data on file, last reported at $44.3 million in Q4 2025.

• Notes Payables for Q4 2025 came in at $44.3 million, down 23.5% year-over-year; the trailing twelve-month figure through Dec 2025 was $44.3 million (down 23.5% YoY), and the FY2025 annual result was $28.0 million, down 51.08% from the prior year.
• Notes Payables advanced to $44.3 million in Q4 2025 per ACB's latest filing, from $43.4 million in the prior quarter.
• Over five years, Notes Payables peaked at $57.9 million in Q4 2024 and troughed at $7.1 million in Q1 2023.
• A 5-year average of $35.7 million and a median of $38.9 million in 2024 frame the typical range for Notes Payables.
• The sharpest annual moves came in 2021 and 2024: Notes Payables plunged 76.81% in 2021, then surged 448.87% in 2024.
• A 5-year view of Notes Payables shows it stood at $42.6 million in 2021, then slumped by 37.47% to $26.6 million in 2022, then surged by 79.89% to $47.9 million in 2023, then grew by 20.84% to $57.9 million in 2024, then declined by 23.5% to $44.3 million in 2025.
• Business Quant data shows ACB's Notes Payables at $44.3 million in Q4 2025, $43.4 million in Q3 2025, and $43.2 million in Q2 2025.